Nanotechnology Now

Our NanoNews Digest Sponsors

Heifer International

Wikipedia Affiliate Button

Home > Press > SENSIMED Triggerfish Clinical Outcomes to Be Presented at ARVO Congress 2013: Sensimed Announces Scientific Presentations on the SENSIMED Triggerfish® System at the 2013 Meeting of the Association for Research in Vision and Ophthalmology (ARVO)

Abstract:
Sensimed AG, announced today that 10 scientific publications reporting outcomes of clinical studies investigating the use of SENSIMED Triggerfish® will be presented at ARVO 2013. The company developed the SENSIMED Triggerfish®, a revolutionary contact lens for the continuous recording of the 24-hour intraocular pressure (IOP) pattern to facilitate the management of glaucoma.

SENSIMED Triggerfish Clinical Outcomes to Be Presented at ARVO Congress 2013: Sensimed Announces Scientific Presentations on the SENSIMED Triggerfish® System at the 2013 Meeting of the Association for Research in Vision and Ophthalmology (ARVO)

Lausanne, Switzerland | Posted on April 24th, 2013

A total of 9 posters were accepted for presentation by the 2013 ARVO Annual Meeting Program Committee. These will be reporting on the use of the SENSIMED Triggerfish® in clinical studies in various locations worldwide. The Poster sessions are titled "Ocular Nanotechnology, Nanoparticles, and Gene Therapy" and "Glaucoma: Intraocular Pressure" and are scheduled in the morning of May 6th and May 9th 2013 respectively.

In addition Sensimed was selected for an oral presentation during the "Nanotechnology and Regenerative Medicine Group: Minimally invasive biometric technology as a means to improve detection, understanding, and treatment of ocular disease" portion of the symposium.

"We are proud to have been selected to present our research on the SENSIMED Triggerfish® to the scientific community at ARVO, especially considering the large number of applicants." commented Jean-Marc Wismer, Chief Executive Officer of Sensimed. "This year's ARVO meeting provides a unique platform for Sensimed to share the continued research with our peers" said René Goedkoop, MD, Chief Medical Officer of Sensimed, "Especially in light of the mounting interest for SENSIMED Triggerfish® in conjuncture with the progressive increase of significant data from clinical studies."

The ARVO congress will take place in Seattle from May 5th to 9th 2013 focusing on encouraging and assisting research, training, publication and knowledge sharing in vision and ophthalmology. With more than 12'000 researchers from over 80 countries, the ARVO is the largest and most respected eye and vision organization.

####

About Sensimed AG
FROM DEVICE TO KNOWLEDGE -- Sensimed AG, a Swiss company, has developed a non-invasive soft contact lens-based solution, the SENSIMED Triggerfish® that revolutionizes glaucoma management by providing continuous 24 hour intraocular pressure (IOP) profiles as well as modeling and analysis of IOP patterns. The 24 hour IOP profiles, centralized on a registry together with patient and treatment information, are processed by powerful modeling and learning algorithms identifying pathological patterns that can be used to differentiate indication and to personalize treatment. Sensimed is directly positioned at the convergence between devices, treatment and information. The company believes that this global knowledge-building approach will enable ophthalmologists to better improve management of patients with potentially progressive glaucoma.

For more information, please click here

Contacts:
SENSIMED AG
phone: +41 21 621 9191

Copyright © Marketwire

If you have a comment, please Contact us.

Issuers of news releases, not 7th Wave, Inc. or Nanotechnology Now, are solely responsible for the accuracy of the content.

Bookmark:
Delicious Digg Newsvine Google Yahoo Reddit Magnoliacom Furl Facebook

Related Links

Sensimed at ARVO:

Related News Press

News and information

In borophene, boundaries are no barrier: Rice U., Northwestern researchers make and test atom-thick boron's unique domains July 17th, 2018

Tuning into quantum: Scientists unlock signal frequency control of precision atom qubits July 16th, 2018

Nano-kirigami: 'Paper-cut' provides model for 3D intelligent nanofabrication July 13th, 2018

UMBC researchers develop nanoparticles to reduce internal bleeding caused by blast trauma July 13th, 2018

Nanomedicine

Nano-kirigami: 'Paper-cut' provides model for 3D intelligent nanofabrication July 13th, 2018

UMBC researchers develop nanoparticles to reduce internal bleeding caused by blast trauma July 13th, 2018

Researchers identify cost-cutting option in treating nail fungus with nanotechnology: GW researcher Adam Friedman, M.D., studied the potential use of nitric oxide-releasing nanoparticles to improve onychomycosis treatment July 11th, 2018

New sensor technology enables super-sensitive live monitoring of human biomolecules July 3rd, 2018

Announcements

In borophene, boundaries are no barrier: Rice U., Northwestern researchers make and test atom-thick boron's unique domains July 17th, 2018

Tuning into quantum: Scientists unlock signal frequency control of precision atom qubits July 16th, 2018

Nano-kirigami: 'Paper-cut' provides model for 3D intelligent nanofabrication July 13th, 2018

UMBC researchers develop nanoparticles to reduce internal bleeding caused by blast trauma July 13th, 2018

Tools

Oxford Instruments’ 22 Tesla superconducting magnet system commissioned at the UAM, making it the most intense magnetic field available outside a large international facility July 12th, 2018

Nanometrics to Announce Second Quarter Financial Results on July 31, 2018 July 12th, 2018

Nanometrics to Participate in the 10th Annual CEO Investor Summit 2018: Accredited investor and publishing research analyst event held concurrently with SEMICON West and Intersolar 2018 in San Francisco June 28th, 2018

The Institute of Applied Physics at the University of Tsukuba near Tokyo in Japan uses Deben's ARM2 detector to better understand catalytic reaction mechanisms June 27th, 2018

Events/Classes

Nanometrics to Announce Second Quarter Financial Results on July 31, 2018 July 12th, 2018

SUNY Poly-Led AIM Photonics and Partners Attend SEMICON West 2018 to Showcase High-Tech Advances, Collaboration, and Future R&D Opportunities: New York’s Tech Valley Makes a Major Showing in Silicon Valley July 3rd, 2018

Arrowhead Presents New Clinical Data on ARO-AAT at Alpha-1 National Education Conference July 1st, 2018

Nanometrics to Participate in the 10th Annual CEO Investor Summit 2018: Accredited investor and publishing research analyst event held concurrently with SEMICON West and Intersolar 2018 in San Francisco June 28th, 2018

Photonics/Optics/Lasers

SUNY Poly-Led AIM Photonics and Partners Attend SEMICON West 2018 to Showcase High-Tech Advances, Collaboration, and Future R&D Opportunities: New York’s Tech Valley Makes a Major Showing in Silicon Valley July 3rd, 2018

Cleaning or Etching Items with Unique Geometries Requires Specialized Expertise June 27th, 2018

Powering the 21st Century with Integrated Photonics: UCSB-Led Team Selected for Demonstration of a Novel Waveguide Platform Which is Transparent Throughout the MWIR and LWIR Spectral Bands June 19th, 2018

Executives Explore Key Megatrends and Innovations in MEMS, Sensors, Imaging Tech at SEMI-MSIG European Summits: Speakers to share developments in smart automotive, smart cities, smart industrial, biomedical, consumer and IoT, September 19-21, 2018 in Grenoble, France June 19th, 2018

NanoNews-Digest
The latest news from around the world, FREE



  Premium Products
NanoNews-Custom
Only the news you want to read!
 Learn More
NanoStrategies
Full-service, expert consulting
 Learn More











ASP
Nanotechnology Now Featured Books




NNN

The Hunger Project